サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1520554

スマート吸入器市場レポート：製品、適応症、流通チャネル、地域別、2024年～2032年

Smart Inhalers Market Report by Product, Indication (Asthma, Chronic Obstructive Pulmonary Disease ), Distribution Channel, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.54円
スマート吸入器市場レポート：製品、適応症、流通チャネル、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

スマート吸入器の世界市場規模は、2023年に2億5,250万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに13億7,060万米ドルに達し、2024年から2032年の間に20.3％の成長率（CAGR）を示すと予測しています。

スマート吸入器は、アドヒアランスを監視し、投与量のリマインダーを送信し、ブルートゥースを介して容易に共有可能な情報へのアクセスを提供し、各投与量の時間、日付、場所を正確に記録できる呼吸器用吸入器です。また、治療へのコンプライアンスを向上させ、症状コントロールへの患者の関与とモチベーションを高め、胸部に影響を及ぼす可能性のある環境や天候に関するレポートを提供することもできます。喘息や慢性閉塞性肺疾患（COPD）の有病率の増加により、世界中でスマート吸入器の需要が増加しています。

スマート吸入器市場動向：

世界の大気汚染レベルの上昇により、慢性呼吸器疾患（CRD）、肺がん、慢性気管支炎、急性下気道感染症（ALRI）の患者数が大幅に増加しています。これは市場の成長を促進する重要な要因の一つです。さらに、従来の吸入器の有効性は、誤った吸入技術や不良なアドヒアランスによって悪影響を受ける可能性があり、その結果、患者の病状が進行する可能性があります。しかし、スマート吸入器は、投薬スケジュールとその後の投与を監視するためのモバイルアプリケーションと接続するように設計されたデジタル機能を使用して、これらの疾患の管理における患者とヘルスケア専門家の課題に対処することができます。さらに、症状が特定の行動を必要とする場合に患者や臨床医に警告を発し、より良いセルフケアへの移行を促進することができます。このことは、吸入技術や正しい服薬アドヒアランスレベルの計算に関するユーザーへのフィードバックを可能にする最近のスマート吸入器技術の進歩と相まって、市場を牽引しています。これに加えて、患者の間でスマート吸入器を使用する利点に関する認識が高まっていることが、全体的な売上高と収益性を増大させると予測されます。

本レポートで扱う主な質問

  • 2023年の世界のスマート吸入器市場の市場規模は？
  • 2024-2032年の世界のスマート吸入器市場の予想成長率は？
  • 世界のスマート吸入器市場に対するCOVID-19の影響は？
  • 世界のスマート吸入器市場を牽引する主要因は？
  • 世界のスマート吸入器市場の製品別内訳は？
  • 世界のスマート吸入器市場の適応症別の内訳は？
  • 世界のスマート吸入器市場の主要地域は？
  • 世界のスマート吸入器市場の主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のスマート吸入器市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 吸入器
    • 市場動向
    • 主要セグメント
      • 乾燥粉末吸入器
      • 定量吸入器
    • 市場予測
  • ネブライザー
    • 市場動向
    • 市場予測

第7章 市場内訳：適応症別

  • 喘息
    • 市場動向
    • 市場予測
  • 慢性閉塞性肺疾患（COPD）
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンラインストア
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • Adherium Limited
    • AptarGroup Inc.
    • AstraZeneca plc
    • Boehringer Ingelheim
    • Cognita Labs
    • GlaxoSmithKline plc
    • Novartis AG
    • OPKO Health Inc.
    • Propeller Health（ResMed）
    • Sensirion AG
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group Limited（Philip Morris International Inc.）
図表

List of Figures

  • Figure 1: Global: Smart Inhalers Market: Major Drivers and Challenges
  • Figure 2: Global: Smart Inhalers Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Smart Inhalers Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Smart Inhalers Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: Smart Inhalers Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Smart Inhalers Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Smart Inhalers (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Smart Inhalers (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Smart Inhalers (Nebulizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Smart Inhalers (Nebulizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Smart Inhalers (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Smart Inhalers (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Smart Inhalers (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Smart Inhalers (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Smart Inhalers (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Smart Inhalers (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Smart Inhalers (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Smart Inhalers (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Smart Inhalers (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Smart Inhalers (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: United States: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: United States: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Canada: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Canada: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia-Pacific: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia-Pacific: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: China: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: China: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Japan: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Japan: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: India: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: India: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: South Korea: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: South Korea: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Australia: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Australia: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Indonesia: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Indonesia: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Others: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Others: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Europe: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Europe: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Germany: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Germany: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: France: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: France: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United Kingdom: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United Kingdom: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Italy: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Italy: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Spain: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Spain: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Russia: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Russia: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Brazil: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Brazil: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Mexico: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Mexico: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Smart Inhalers Market: Breakup by Country (in %), 2023
  • Figure 70: Middle East and Africa: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: Smart Inhalers Industry: SWOT Analysis
  • Figure 72: Global: Smart Inhalers Industry: Value Chain Analysis
  • Figure 73: Global: Smart Inhalers Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Smart Inhalers Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Smart Inhalers Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Smart Inhalers Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Smart Inhalers Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Smart Inhalers Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Smart Inhalers Market: Competitive Structure
  • Table 7: Global: Smart Inhalers Market: Key Players
目次
Product Code: SR112024A5417

The global smart inhalers market size reached US$ 252.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,370.6 Million by 2032, exhibiting a growth rate (CAGR) of 20.3% during 2024-2032.

Smart inhalers are respiratory inhalers that can monitor adherence, send dosage reminders, offer access to readily shareable information via Bluetooth, and record the time, date and location of each dosage administered accurately. They can also help improve compliance with therapy, increase patient involvement and motivation in controlling symptoms, and provide reports about environmental and weather conditions that may affect their chest. Due to the growing prevalence of asthma and chronic obstructive pulmonary diseases (COPD), there is a rise in the demand for smart inhalers across the globe.

Smart Inhalers Market Trends:

Due to a rise in air pollution levels worldwide, there is a significant increase in the number of patients with chronic respiratory diseases (CRDs), lung cancer, chronic bronchitis, and acute lower respiratory infections (ALRI). This represents one of the key factors propelling the growth of the market. Moreover, the efficacy of conventional inhalers can be negatively impacted by incorrect inhaler techniques and poor adherence, which may result in the progression of patients' condition. However, smart inhalers can address the challenges of patients and healthcare professionals in the management of these diseases using digital features designed to connect with mobile applications for monitoring medication schedules and subsequent dosing. Additionally, they can alert patients and clinicians when symptoms require specific action and facilitate a shift to better self-care. This, coupled with recent advances in smart inhaler technology, which allow feedback to users on their inhaler technique and the calculation of the correct level of adherence, is driving the market. Besides this, the increasing awareness about the benefits of using smart inhalers among patients is projected to augment the overall sales and profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global smart inhalers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, indication and distribution channel.

Breakup by Product:

Inhalers

Dry Powdered Inhaler

Metered Dose Inhaler

Nebulizers

Breakup by Indication:

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Stores

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Adherium Limited, AptarGroup Inc., AstraZeneca plc, Boehringer Ingelheim, Cognita Labs, GlaxoSmithKline plc, Novartis AG, OPKO Health Inc., Propeller Health (ResMed), Sensirion AG, Teva Pharmaceutical Industries Ltd. and Vectura Group Limited (Philip Morris International Inc.).

Key Questions Answered in This Report

  • 1. What was the size of the global smart inhalers market in 2023?
  • 2. What is the expected growth rate of the global smart inhalers market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global smart inhalers market?
  • 4. What are the key factors driving the global smart inhalers market?
  • 5. What is the breakup of the global smart inhalers market based on the product?
  • 6. What is the breakup of the global smart inhalers market based on the indication?
  • 7. What is the breakup of the global smart inhalers market based on distribution channel?
  • 8. What are the key regions in the global smart inhalers market?
  • 9. Who are the key players/companies in the global smart inhalers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Smart Inhalers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Dry Powdered Inhaler
      • 6.1.2.2 Metered Dose Inhaler
    • 6.1.3 Market Forecast
  • 6.2 Nebulizers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Adherium Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AptarGroup Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 AstraZeneca plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boehringer Ingelheim
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Cognita Labs
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 GlaxoSmithKline plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 OPKO Health Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Propeller Health (ResMed)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sensirion AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Teva Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Vectura Group Limited (Philip Morris International Inc.)
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis